Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 10, 2009
Mon, February 9, 2009
Sun, February 8, 2009
Fri, February 6, 2009 Del Medical Systems Group Wins Major Government Tender in Mexico
FRANKLIN PARK, Ill.--([ BUSINESS WIRE ])--Del Global Technologies Corp. (OTCBB:DGTC) ("Del Global" or "the Company") today announced the winning of a large government tender in Mexico. Del's seamless product specifications, local service, expedient delivery times and comprehensive warranty were key factors in Mexico's decision to award the tender. Local support services are to be provided by Del's in-country dealer Suministro para Uso Médico y Hospitalario (SMH).
According to Belisario Jasso, General Director at SMH, "Mexico's government scrutinized Del's local presence carefully before making the award. As it stands in order to be considered a relevant business partner to the Government here, having a strong local presence is always a mitigating factor."
The Mexican Government plans to install sixApollo Systems for the Mexico City Government Health Services, four Digital Apollo Systems for the ISSSTE (Government Workers Health and Social Institute) and eight Del RAD Systems for the ISEM (Health Services for the State of Mexico). The Apollo units were manufactured by Villa Sistemi Medicali in Italy and were shipped to Mexico in December of 2008. Jasso says, "The first units will be installed in Mexico in January of 2009."
According to Dennis Runyan, Vice President of Global Sales & Marketing for the Del Medical Systems Group, "Del Medical is known for product quality and reliability, so we choose our international dealer relationships carefully. SMH is a leading sales and support provider of advanced imaging technology with installations in major hospitals throughout the Mexican Republic. Our relationship with SMH extends the geographic reach of our digital radiography portfolio and capabilities to our global customers like the Mexican Government. Our global dealers are chosen carefully as we rely on them to provide the same quality and support that our customers have grown to expect over the last eighty years of being in business."
ABOUT DEL GLOBAL TECHNOLOGIES
Del Global Technologies Corp. is primarily engaged in the design, manufacture and marketing of high performance diagnostic imaging systems for medical, dental and veterinary applications through the Del Medical Systems Group. Through its U.S. based Del Medical Imaging Corp. and Milan, Italy based Villa Sistemi Medicali S.p.A. subsidiaries the Company offers a broad portfolio of general radiographic, radiographic/fluoroscopic, portable x-ray and digital radiographic systems to the global marketplace. Through its RFI subsidiary, Del Global manufactures proprietary high-voltage power conversion subsystems including electronic filters, high voltage capacitors, pulse modulators, transformers and reactors, and a variety of other products designed for industrial, medical, military and other commercial applications. The company's web site is [ www.delglobal.com ].
Statements about future results made in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and the current economic environment. Del Global cautions that these statements are not guarantees of future performance. These statements involve a number of risks and uncertainties that are difficult to predict, including, but not limited to: the ability of Del Global to introduce products as scheduled; obtaining necessary product certification; implement its business plan; retention of management; changing industry and competitive conditions; obtaining anticipated operating efficiencies; securing necessary capital facilities; favorable determinations in various legal matters; market and operating risks from foreign currency exchange exposures; and favorable general economic conditions. Actual results could differ materially from those expressed or implied in the forward-looking statements. Important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements are specified in the Company's filings with the Securities and Exchange Commission.
